Copyright Reports & Markets. All rights reserved.

Global CRISPR and CRISPR-Associated (Cas) Genes Market Insights and Forecast to 2027

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 CRISPR and CRISPR-Associated (Cas) Genes Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Type
    • 1.4.2 Genome Editing
    • 1.4.3 Genetic Engineering
    • 1.2.4 gRNA Database/Gene Librar
    • 1.2.5 CRISPR Plasmid
    • 1.2.6 Human Stem Cells
    • 1.2.7 Genetically Modified Organisms/Crops
    • 1.2.8 Cell Line Engineering
  • 1.3 Market by Application
    • 1.3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Application
    • 1.3.2 Biotechnology Companies
    • 1.3.3 Pharmaceutical Companies
    • 1.3.4 Academic Institutes
    • 1.3.5 Research and Development Institutes
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Estimates and Forecasts 2016-2027
  • 2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Estimates and Forecasts 2016-2027
  • 2.3 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Region: 2016 VS 2021 VS 2027
  • 2.4 Global Top CRISPR and CRISPR-Associated (Cas) Genes Regions by Sales
    • 2.4.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Regions by Sales (2016-2021)
    • 2.4.2 Global Top CRISPR and CRISPR-Associated (Cas) Genes Regions by Sales (2022-2027)
  • 2.5 Global Top CRISPR and CRISPR-Associated (Cas) Genes Regions by Revenue
    • 2.5.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Regions by Revenue (2016-2021)
    • 2.5.2 Global Top CRISPR and CRISPR-Associated (Cas) Genes Regions by Revenue (2022-2027)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Manufacturers
    • 3.1.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Manufacturers by Sales (2016-2021)
    • 3.1.2 Global Top CRISPR and CRISPR-Associated (Cas) Genes Manufacturers Market Share by Sales (2016-2021)
    • 3.1.3 Global Top 10 and Top 5 Companies by CRISPR and CRISPR-Associated (Cas) Genes Sales in 2020
  • 3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Manufacturers
    • 3.2.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Manufacturers by Revenue (2016-2021)
    • 3.2.2 Global Top CRISPR and CRISPR-Associated (Cas) Genes Manufacturers Market Share by Revenue (2016-2021)
    • 3.2.3 Global Top 10 and Top 5 Companies by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2020
  • 3.3 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Price by Manufacturers
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global CRISPR and CRISPR-Associated (Cas) Genes Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Type
    • 4.1.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historical Sales by Type (2016-2021)
    • 4.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Sales by Type (2022-2027)
    • 4.1.3 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2016-2027)
  • 4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type
    • 4.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historical Revenue by Type (2016-2021)
    • 4.2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Revenue by Type (2022-2027)
    • 4.2.3 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2016-2027)
  • 4.3 Global CRISPR and CRISPR-Associated (Cas) Genes Price by Type
    • 4.3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Price by Type (2016-2021)
    • 4.3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Price Forecast by Type (2022-2027)

5 Market Size by Application

  • 5.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Application
    • 5.1.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historical Sales by Application (2016-2021)
    • 5.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Sales by Application (2022-2027)
    • 5.1.3 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2016-2027)
  • 5.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application
    • 5.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historical Revenue by Application (2016-2021)
    • 5.2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Revenue by Application (2022-2027)
    • 5.2.3 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2016-2027)
  • 5.3 Global CRISPR and CRISPR-Associated (Cas) Genes Price by Application
    • 5.3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Price by Application (2016-2021)
    • 5.3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Price Forecast by Application (2022-2027)

6 North America

  • 6.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
    • 6.1.1 North America CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2016-2027)
    • 6.1.2 North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2016-2027)
  • 6.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
    • 6.2.1 North America CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2016-2027)
    • 6.2.2 North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2016-2027)
  • 6.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
    • 6.3.1 North America CRISPR and CRISPR-Associated (Cas) Genes Sales by Country (2016-2027)
    • 6.3.2 North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2016-2027)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
    • 7.1.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2017-2027)
    • 7.1.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2017-2027)
  • 7.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
    • 7.2.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2017-2027)
    • 7.2.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2017-2027)
  • 7.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
    • 7.3.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Country (2017-2027)
    • 7.3.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2017-2027)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
    • 8.1.1 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2018-2027)
    • 8.1.2 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2018-2027)
  • 8.2 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
    • 8.2.1 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2018-2027)
    • 8.2.2 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2018-2027)
  • 8.3 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region
    • 8.3.1 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Sales by Region (2018-2027)
    • 8.3.2 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue by Region (2018-2027)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
    • 9.1.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2019-2027)
    • 9.1.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2019-2027)
  • 9.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
    • 9.2.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2019-2027)
    • 9.2.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2019-2027)
  • 9.3 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
    • 9.3.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Sales by Country (2019-2027)
    • 9.3.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2019-2027)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

6 Middle East and Africa

  • 6.1 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
    • 6.1.1 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2016-2027)
    • 6.1.2 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2016-2027)
  • 6.2 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
    • 6.2.1 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2016-2027)
    • 6.2.2 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2016-2027)
  • 6.3 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
    • 6.3.1 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Sales by Country (2016-2027)
    • 6.3.2 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2016-2027)
    • 6.3.3 Turkey
    • 6.3.4 Saudi Arabia
    • 6.3.5 U.A.E

11 Company Profiles

  • 11.1 Caribou Biosciences
    • 11.1.1 Caribou Biosciences Corporation Information
    • 11.1.2 Caribou Biosciences Overview
    • 11.1.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Description
    • 11.1.5 Caribou Biosciences Related Developments
  • 11.2 Addgene
    • 11.2.1 Addgene Corporation Information
    • 11.2.2 Addgene Overview
    • 11.2.3 Addgene CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.2.4 Addgene CRISPR and CRISPR-Associated (Cas) Genes Product Description
    • 11.2.5 Addgene Related Developments
  • 11.3 CRISPR THERAPEUTICS
    • 11.3.1 CRISPR THERAPEUTICS Corporation Information
    • 11.3.2 CRISPR THERAPEUTICS Overview
    • 11.3.3 CRISPR THERAPEUTICS CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.3.4 CRISPR THERAPEUTICS CRISPR and CRISPR-Associated (Cas) Genes Product Description
    • 11.3.5 CRISPR THERAPEUTICS Related Developments
  • 11.4 Merck KGaA
    • 11.4.1 Merck KGaA Corporation Information
    • 11.4.2 Merck KGaA Overview
    • 11.4.3 Merck KGaA CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.4.4 Merck KGaA CRISPR and CRISPR-Associated (Cas) Genes Product Description
    • 11.4.5 Merck KGaA Related Developments
  • 11.5 Mirus Bio LLC
    • 11.5.1 Mirus Bio LLC Corporation Information
    • 11.5.2 Mirus Bio LLC Overview
    • 11.5.3 Mirus Bio LLC CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.5.4 Mirus Bio LLC CRISPR and CRISPR-Associated (Cas) Genes Product Description
    • 11.5.5 Mirus Bio LLC Related Developments
  • 11.6 Editas Medicine
    • 11.6.1 Editas Medicine Corporation Information
    • 11.6.2 Editas Medicine Overview
    • 11.6.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.6.4 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product Description
    • 11.6.5 Editas Medicine Related Developments
  • 11.7 Takara Bio USA
    • 11.7.1 Takara Bio USA Corporation Information
    • 11.7.2 Takara Bio USA Overview
    • 11.7.3 Takara Bio USA CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.7.4 Takara Bio USA CRISPR and CRISPR-Associated (Cas) Genes Product Description
    • 11.7.5 Takara Bio USA Related Developments
  • 11.8 Thermo Fisher Scientific
    • 11.8.1 Thermo Fisher Scientific Corporation Information
    • 11.8.2 Thermo Fisher Scientific Overview
    • 11.8.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.8.4 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product Description
    • 11.8.5 Thermo Fisher Scientific Related Developments
  • 11.9 Horizon Discovery Group
    • 11.9.1 Horizon Discovery Group Corporation Information
    • 11.9.2 Horizon Discovery Group Overview
    • 11.9.3 Horizon Discovery Group CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.9.4 Horizon Discovery Group CRISPR and CRISPR-Associated (Cas) Genes Product Description
    • 11.9.5 Horizon Discovery Group Related Developments
  • 11.10 Intellia Therapeutics
    • 11.10.1 Intellia Therapeutics Corporation Information
    • 11.10.2 Intellia Therapeutics Overview
    • 11.10.3 Intellia Therapeutics CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.10.4 Intellia Therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product Description
    • 11.10.5 Intellia Therapeutics Related Developments
  • 11.1 Caribou Biosciences
    • 11.1.1 Caribou Biosciences Corporation Information
    • 11.1.2 Caribou Biosciences Overview
    • 11.1.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Description
    • 11.1.5 Caribou Biosciences Related Developments

12 Value Chain and Sales Channels Analysis

  • 12.1 CRISPR and CRISPR-Associated (Cas) Genes Value Chain Analysis
  • 12.2 CRISPR and CRISPR-Associated (Cas) Genes Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 CRISPR and CRISPR-Associated (Cas) Genes Production Mode & Process
  • 12.4 CRISPR and CRISPR-Associated (Cas) Genes Sales and Marketing
    • 12.4.1 CRISPR and CRISPR-Associated (Cas) Genes Sales Channels
    • 12.4.2 CRISPR and CRISPR-Associated (Cas) Genes Distributors
  • 12.5 CRISPR and CRISPR-Associated (Cas) Genes Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 CRISPR and CRISPR-Associated (Cas) Genes Industry Trends
  • 13.2 CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
  • 13.3 CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
  • 13.4 CRISPR and CRISPR-Associated (Cas) Genes Market Restraints

14 Key Findings in The Global CRISPR and CRISPR-Associated (Cas) Genes Study

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    CRISPR and CRISPR-Associated (Cas) Genes market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global CRISPR and CRISPR-Associated (Cas) Genes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

    Segment by Type
    Genome Editing
    Genetic Engineering
    gRNA Database/Gene Librar
    CRISPR Plasmid
    Human Stem Cells
    Genetically Modified Organisms/Crops
    Cell Line Engineering

    Segment by Application
    Biotechnology Companies
    Pharmaceutical Companies
    Academic Institutes
    Research and Development Institutes

    By Company
    Caribou Biosciences
    Addgene
    CRISPR THERAPEUTICS
    Merck KGaA
    Mirus Bio LLC
    Editas Medicine
    Takara Bio USA
    Thermo Fisher Scientific
    Horizon Discovery Group
    Intellia Therapeutics
    GE Healthcare Dharmacon

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia

    Buy now